Combined PD-1 and CTLA-4 Blockade Increases the Risks of Multiple Pituitary Hormone Deficiency and Isolated Adrenocorticotropic Deficiency: A Prospective Study

Combined PD-1 and CTLA-4 Blockade Increases the Risks of Multiple Pituitary Hormone Deficiency and Isolated Adrenocorticotropic Deficiency: A Prospective Study

Background Anti-cytotoxic T-lymphocyte antigen-4 antibody (CTLA-4-Ab) monotherapy induces two types of pituitary immunerelated adverse events (irAEs): multiple pituitary hormone deficiency (Multi-D; impairment of ≥2 anterior pituitary hormones) and isolated adrenocorticotropic hormone (ACTH) deficie...

Full description

Saved in:
Bibliographic Details
Main Authors: Shintaro Iwama, Tomoko Kobayashi, Tetsushi Izuchi, Koji Suzuki, Takanori Murase, Masahiko Ando, Tomoko Handa, Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Tetsunari Hase, Shoichiro Mori, Tomoyasu Sano, Shusuke Akamatsu, Masashi Akiyama, Makoto Ishii, Hiroshi Arima
Format: Article
Language:English
Published: Korean Endocrine Society 2025-06-01
Series:Endocrinology and Metabolism
Subjects:
hypopituitarism
adrenocorticotropic hormone deficiency
immune checkpoint inhibitors
immunotherapy
immunerelated adverse event
Online Access:http://www.e-enm.org/upload/pdf/enm-2024-2180.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.e-enm.org/upload/pdf/enm-2024-2180.pdf

Similar Items